Readgene

WAR:RDG Poland Biotechnology & Medical Research
Market Cap
$12.97K
zł53.92K PLN
Market Cap Rank
#44563 Global
#446 in Poland
Share Price
zł5.46
Change (1 day)
+0.00%
52-Week Range
zł4.29 - zł5.82
All Time High
zł6.60
About

Readgene operates in Biotechnology.

Readgene (RDG) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: -0.059x

Based on the latest financial reports, Readgene (RDG) has a cash flow conversion efficiency ratio of -0.059x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-88.37K) by net assets (zł1.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Readgene - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how Readgene's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Readgene Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Readgene ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Readgene (2016–2023)

The table below shows the annual cash flow conversion efficiency of Readgene from 2016 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 zł4.16 Million zł-820.82K -0.197x -412.23%
2022-12-31 zł5.51 Million zł347.90K 0.063x +222.02%
2021-12-31 zł5.42 Million zł106.26K 0.020x -94.44%
2020-12-31 zł3.04 Million zł1.07 Million 0.353x +145.94%
2019-12-31 zł3.24 Million zł-2.49 Million -0.768x -524.63%
2018-12-31 zł3.14 Million zł-386.33K -0.123x +14.68%
2017-12-31 zł2.36 Million zł-340.03K -0.144x -189.05%
2016-12-31 zł2.98 Million zł481.60K 0.162x --